It Takes a Team to Build Personalized Care for Type 2 Diabetes

Video

Diana McNeill, MD, of Duke University Medical Center moderated a panel at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California. The topic of discussion? Personalized care in type 2 diabetes.

It goes without saying that not every patient with the same health condition is similar. In the case of type 2 diabetes, teamwork can better help patients manage their disease with personalized care.

Diana McNeill, MD, professor of medicine and assistant professor of obstetrics and gynecology at Duke University Medical Center in Durham, North Carolina moderated a panel at the American College of Physicians Internal Medicine Meeting (ACP 2017) in San Diego, California. With panelists Steven Edelman, MD, and M. Sue Kirkman, MD, the physicians talked about preventing clinical inertia in the management of type 2 diabetes and the importance of personalized care.

McNeill spoke with MD Magazine about the discussion and said that the type 2 diabetes epidemic puts many patients in front of primary care physicians before an endocrinologist.

“When a patient comes into your office, do you examine them and check their feet and make sure that they’ve had all their diabetes healthcare maintenance completed?” McNeill said. “And once you do do that, what target of diabetes control are you aiming for? And is it appropriate for their age and comorbidities?”

She went on to explain that the American Diabetes Association has changed their thinking on the goals of type 2 diabetes care. How? Watch the video above and gain insight on personalized care.

>>> More Coverage from ACP 2017

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.